Superior growth parameters and a potentially flourishing domestic market are factors delighting long-term investors. At the same time, they are hesitant to go all out on the country’s stocks at this juncture as over-ownership of equities and premium valuations are pushing many value-conscious money managers to delay their purchases here.
AMFI Reshuffle: Five midcap stocks that may get upgraded to largecap
Nuvama Institutional Equities expects five midcap stocks, including Bosch, Zydus Lifesciences and Lodha Developers, to move into the largecap category in AMFI’s H1 CY27 reclassification.